EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG

The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to, pDTG-based ART to ensure that:

  1. the pDTG is being administered in the correct dosage and frequency;

  2. health care workers and caregivers check for adverse drug reactions and signs of intolerance; and

  3. follow-up is performed for scheduled clinical and ART pickup visits.


The algorithm should be adapted to the country-specific context, policies, and guidelines, specifically to align with a country’s multi-month dispensing (MMD) and viral load testing schedules. Most countries currently allow MMD, mostly for children greater than 2 years old.